COMPOSITION INDUCING DIFFERENTIATION OF CANCER CELL, CONTAINING DECURSIN AS AN ACTIVE COMPONENT
PURPOSE: A composition inducing differentiation of cancer cell, more specifically human leukemia cell, containing decursin as an active component and a pharmaceutically acceptable carrier is provided. tonicity adjustment agent. CONSTITUTION: A composition inducing differentiation of cancer cell cont...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PURPOSE: A composition inducing differentiation of cancer cell, more specifically human leukemia cell, containing decursin as an active component and a pharmaceutically acceptable carrier is provided. tonicity adjustment agent. CONSTITUTION: A composition inducing differentiation of cancer cell contains decursin extracted from Angelica gigas Nakai which is known as cytotoxic material, as a pharmaceutically active component, pharmaceutically acceptable carrier, vehicle such as lactose, starch and the like, and optionally containing lubricating agent such as magnesium stearate, emulsifying agent, suspensions, tonicity adjustment agent and other additives. The composition can be formulated into various types. The dosage can be varied, for example 1-300mg per weight kilogram.
본 발명은 데커신(decursin)을 유효성분으로 포함하고 약제학적으로 허용가능한 담체를 포함하는 암세포 분화유도제 조성물 특히, 인체 백혈병 암세포 분화유도제 조성물에 관한 것이다. |
---|